Cited 2 time in webofscience Cited 1 time in scopus

The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 alpha 1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults

Title
The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 alpha 1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults
Authors
Kim, Eun Hee G.Kwak, Soo HeonHwang, Dae HeeYi, Eu Gene C.Park, Kyong SooKoo, Bo KyungKim, Kristine M.
DGIST Authors
Kim, Eun Hee G.; Kwak, Soo Heon; Hwang, Dae Hee; Yi, Eu Gene C.; Park, Kyong Soo; Koo, Bo Kyung; Kim, Kristine M.
Issue Date
2016-04
Citation
Diabetes and Metabolism Journal, 40(2), 154-160
Type
Article
Article Type
Article
Author Keywords
AutoantibodiesDiabetes mellitustype 1Eukaryote translation elongation factor 1 alpha 1 autoantibodyUbiquitin-conjugating enzyme 2L3 autoantibody
Keywords
GLUTAMIC-ACID DECARBOXYLASEEXPRESSIONAUTOIMMUNITYPROGRESSIONANTIBODIESRISKGENEGADAGESUSCEPTIBILITY
ISSN
2233-6079
Abstract
Background: The prevalence of novel type 1 diabetes mellitus (T1DM) antibodies targeting eukaryote translation elongation factor 1 alpha 1 autoantibody (EEF1A1-AAb) and ubiquitin-conjugating enzyme 2L3 autoantibody (UBE2L3-AAb) has been shown to be negatively correlated with age in T1DM subjects. Therefore, we aimed to investigate whether age affects the levels of these two antibodies in nondiabetic subjects. Methods: EEF1A1-AAb and UBE2L3-AAb levels in nondiabetic control subjects (n=150) and T1DM subjects (n=101) in various ranges of age (18 to 69 years) were measured using an enzyme-linked immunosorbent assay. The cutoffpoint for the presence of each autoantibody was determined based on control subjects using the formula: [mean absorbance+3×standard deviation]. Results: In nondiabetic subjects, there were no significant correlations between age and EEF1A1-AAb and UBE2L3-AAb levels. However, there was wide variation in EEF1A1-AAb and UBE2L3-AAb levels among control subjects < 40 years old; the prevalence of both EEF1A1-AAb and UBE2L3-AAb in these subjects was 4.4%. When using cutoffpoints determined from the control subjects < 40 years old, the prevalence of both autoantibodies in T1DM subjects was decreased (EEFA1-AAb, 15.8% to 8.9%; UBE2L3-AAb, 10.9% to 7.9%) when compared to the prevalence using the cutoffderived from the totals for control subjects. Conclusion: There was no association between age and EEF1A1-AAb or UBE2L3-AAb levels in nondiabetic subjects. However, the wide variation in EEF1A1-AAb and UBE2L3-AAb levels apparent among the control subjects < 40 years old should be taken into consideration when determining the cutoffreference range for the diagnosis of T1DM. © 2016 Korean Diabetes Association.
URI
http://hdl.handle.net/20.500.11750/2307
DOI
10.4093/dmj.2016.40.2.154
Publisher
Korean Diabetes Association
Files:
There are no files associated with this item.
Collection:
Department of New BiologySystems Biology and Medicine Lab1. Journal Articles


qrcode mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE